Dr Gregory and his team are committed to solving the puzzle that is prostate cancer and saving the lives of so many Australian men.

Scientists working tirelessly in the lab of the Centre for Cancer Biology have identified that high levels of a protein (called quaking) plays a key role in the bad prognosis of prostate cancer tumours that have become resistant to chemotherapy and other treatments.

They have also found this protein is higher in patients with prostate cancer that goes on to spread to other parts of the body, becoming more difficult to treat.

Dr Gregory and the team“We’ve made really good progress in our research since securing funding earlier in 2018,” Dr Gregory explained.

“We screened a very large cohort of prostate cancer patients, in collaboration with colleagues in Canada, finding exactly what we had hoped – that high levels of this protein do indeed correlate with a bad prognosis for prostate cancer and the spread of this disease.

“This now means we can start our work in developing models where we can manipulate this protein and look at its effect on cancer cells in the hope to lead to new treatments for aggressive, hard to treat prostate cancer.”

We look forward to updating you on the next phase of this research in 2019!

support the centre for cancer biology

you may also like...

An Inspiring Fundraising Event

It was another incredible effort by the Ladies Auxiliary of the Cyprus Community who raised $3,500 for vital research into prostate cancer through The Hospital Research Foundation (THRF). read more

A New Pathway to Stopping the Spread of Prostate Cancer

An exciting project set to explore a newly discovered pathway that could lead to new treatments for metastatic prostate cancer is now underway at the Centre for Cancer Biology. Supported by The Hospital Research Foundation, with partner Australian Prostate Cancer, this incredible, innovative research is set to save lives. read more

Fighting Cancer with Your Own Immune System

Ground-breaking research is underway boosting the body’s own immune system to fight the most common cancers affecting Australian families, including breast cancer. The treatment is known as immunotherapy, and whilst it’s currently revolutionising blood cancer treatment, when it comes to solid cancers like breast cancer it’s not known to be as effective. read more

The Fight to Beat Prostate Cancer

Based at the Basil Hetzel Institute for Translational Health Research (BHI), breast cancer researcher Irene Zinonos is now part of a collaborative word-first prostate cancer research project. Led by the University of Adelaide’s Associate Professor Lisa Butler, this project aims to help quickly identify life-threatening cases of prostate cancer, compared with cancer that may not require treatment. read more

Predicting Prostate Cancer Patient Outcomes

A Prostate Cancer Researcher at the University of Adelaide and winner in THRF’s 50th Anniversary Awards, Dr Rajdeep Das’s research will open up new and exciting avenues for personalised cancer medicine for prostate cancer patients. read more

PROSTMATE empowers patients and carers

Online resource PROSTMATE is making a huge difference to patients and families dealing with prostate cancer. PROSTMATE is partly funded by The Hospital Research Foundation’s disease specific affiliate Australian Prostate Cancer, in collaboration with Australian Prostate Cancer Research. read more